Örebro University Hospital is a university hospital in Örebro, Sweden. The hospital is operated by Örebro County Council and took its current name in 2000, having previously been called Örebro Regional Hospital.

There are 462 (2015-02-06) beds in Universitetssjukhuset Örebro, Onkologiska kliniken.

During the past decade, Universitetssjukhuset Örebro, Onkologiska kliniken conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Universitetssjukhuset Örebro, Onkologiska kliniken" are "Breast Cancer" (1 trials) and "Neoplasms" (1 trials). Many other conditions were trialed in "Universitetssjukhuset Örebro, Onkologiska kliniken" in a lesser frequency.

Most popular intervention types in "Universitetssjukhuset Örebro, Onkologiska kliniken" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "5-Fluorouracil" (1 trials), "Bevacizumab" (1 trials), "Cyclophosphamide" (1 trials), "Docetaxel" (1 trials) and "Doxorubicin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitetssjukhuset Örebro, Onkologiska kliniken" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Universitetssjukhuset Örebro, Onkologiska kliniken". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Universitetssjukhuset Örebro, Onkologiska kliniken, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitetssjukhuset Örebro, Onkologiska kliniken, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".